Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Stoke Therapeutics Inc
(NQ:
STOK
)
15.49
+0.46 (+3.06%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Stoke Therapeutics Inc
< Previous
1
2
3
4
5
6
Next >
Stocks That Hit 52-Week Lows On Thursday
May 26, 2022
On Thursday, 94 companies set new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
May 25, 2022
On Wednesday, 215 companies set new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
April 26, 2022
During Tuesday, 581 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week Lows Meta Platforms (NASDAQ:FB) was the biggest company on a market cap basis to set a new 52-week low.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
May 24, 2022
On Tuesday, 540 companies set new 52-week lows.
Via
Benzinga
Recap: Stoke Therapeutics Q1 Earnings
May 10, 2022
Stoke Therapeutics (NASDAQ:STOK) reported its Q1 earnings results on Tuesday, May 10, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings Stoke Therapeutics reported...
Via
Benzinga
Stoke Therapeutics Reports First Quarter Financial Results and Provides Business Updates
May 10, 2022
From
Stoke Therapeutics, Inc.
Via
Business Wire
Stocks That Hit 52-Week Lows On Wednesday
May 04, 2022
During Wednesday's trading, 435 companies set new 52-week lows.
Via
Benzinga
Stoke Therapeutics Presents New In-Vivo Data That Demonstrated Dose-Related Target Engagement and OPA1 Protein Upregulation in Retinal Tissue Following Administration of STK-002
May 02, 2022
From
Stoke Therapeutics, Inc.
Via
Business Wire
Stoke Therapeutics to Present at The Association for Research in Vision and Ophthalmology (ARVO) 2022 Annual Meeting
April 07, 2022
From
Stoke Therapeutics, Inc.
Via
Business Wire
Stoke Therapeutics to Present at the 21st Annual Needham Virtual Healthcare Conference
April 05, 2022
From
Stoke Therapeutics, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session
March 23, 2022
Gainers Greenwich LifeSciences (NASDAQ:GLSI) stock moved upwards by 9.6% to $23.84 during Wednesday's after-market session. The market value of their outstanding shares is at $312.8 million. As per the...
Via
Benzinga
Recap: Stoke Therapeutics Q4 Earnings
March 10, 2022
Stoke Therapeutics (NASDAQ:STOK) reported its Q4 earnings results on Thursday, March 10, 2022 at 07:00 AM. Here's what investors need to know about the announcement....
Via
Benzinga
Stoke Therapeutics to Participate in the Cowen 42nd Annual Health Care Conference
February 28, 2022
From
Stoke Therapeutics, Inc.
Via
Business Wire
Acadia, Stoke Team Up In $900M+ Deal On RNA Therapies For CNS Disorders
January 10, 2022
Acadia Pharmaceuticals Inc (NASDAQ: ACAD) and Stoke Therapeutics Inc (NASDAQ: STOK) will team up on the treatments in rare genetic neurodevelopmental diseases of...
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
February 03, 2022
On Thursday, 105 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week Lows And Highs: Meta Platforms (NASDAQ:FB) was the biggest company on...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 31, 2022
January 31, 2022
Upgrades UBS upgraded the previous rating for Align Technology Inc (NASDAQ:ALGN) from Neutral to Buy. For the third quarter, Align Tech had an EPS of $2.87, compared to year-ago...
Via
Benzinga
Acadia Pharmaceuticals and Stoke Therapeutics Announce Collaboration to Pursue Multiple RNA-based Treatments for Severe and Rare Genetic Neurodevelopmental Diseases
January 10, 2022
From
Acadia Pharmaceuticals Inc.
Via
Business Wire
Stoke Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference
January 04, 2022
From
Stoke Therapeutics, Inc.
Via
Business Wire
Stoke Touts Early Signs Of Efficacy For Antisense Drug In Dravet Syndrome
December 03, 2021
Stoke Therapeutics Inc (NASDAQ: STOK) announced highlights from five presentations related to the ongoing clinical development of STK-001 being made at the American...
Via
Benzinga
Stoke Therapeutics Presents Data from the Phase 1/2a MONARCH Study of STK-001 in Children and Adolescents with Dravet Syndrome at the American Epilepsy Society (AES) 2021 Annual Meeting
December 03, 2021
From
Stoke Therapeutics, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For December 3, 2021
December 03, 2021
Upgrades Cowen & Co. upgraded the previous rating for Marvell Technology Inc (NASDAQ:
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
November 22, 2021
Gainers iSpecimen (NASDAQ:ISPC) stock moved upwards by 95.32% to $9.61 during Monday's regular session. Trading volume for iSpecimen's stock is 70.9 million as of...
Via
Benzinga
61 Biggest Movers From Yesterday
November 23, 2021
Gainers Longeveron Inc. (NASDAQ: LGVN) shares surged 181.2% to settle at $28.20 on Monday on continued upward momentum after the company last week announced the FDA granted Rare...
Via
Benzinga
Exposures
Product Safety
40 Stocks Moving In Monday's Mid-Day Session
November 22, 2021
Gainers iSpecimen Inc. (NASDAQ: ISPC) shares climbed 126.5% to $11.12 after the company announced it has been contracted to support new advanced research on COVID-19 seeking...
Via
Benzinga
Exposures
COVID-19
Benzinga's Top Ratings Upgrades, Downgrades For November 22, 2021
November 22, 2021
Upgrades According to Evercore ISI Group, the prior rating for Kimco Realty Corp (NYSE:
Via
Benzinga
Stoke Therapeutics Announces Presentations from the Company’s Dravet Syndrome Program at the American Epilepsy Society 2021 Annual Meeting
November 19, 2021
From
Stoke Therapeutics, Inc.
Via
Business Wire
Stoke Therapeutics Reports Third Quarter Financial Results and Provides Business Updates
November 08, 2021
From
Stoke Therapeutics, Inc.
Via
Business Wire
Stoke Therapeutics to Present at Upcoming Investor Conferences in November
November 03, 2021
From
Stoke Therapeutics, Inc.
Via
Business Wire
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
October 08, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 7) Alkermes plc (NASDAQ: ALKS)...
Via
Benzinga
Exposures
Product Safety
The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
October 07, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) Enanta Pharmaceuticals, Inc...
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.